Quote:

---

Ohm, do you see any new, noteworthy items in this preprint? Is this further proof that Leronlimab will likely be beneficial for Alzheimer's?

---

I wouldn't say there's anything new, but it is supportive of what's already known. What we already know of both Alzheimer's and Long Covid and the negative effects of overactive immune response and inflammation continue to support leronlimab's use in both.